The key factors contributing to the early stages of atherosclerosis and plaque development include the pro-inflammatory cytokine interferon (IFN)α and IFNγ and the pattern recognition receptor (PRR) Toll-like receptor 4 (TLR4) (Szelag et al., 2016). The gene discussed is TLR4; the disease is atherosclerosis.